NCT07535853

Brief Summary

The purpose of this study is to evaluate the effect of low-power laser therapy on pain intensity and functional outcomes in patients diagnosed with Thoracic Outlet Syndrome (TOS). Participants will be randomly assigned to either receive the active laser therapy combined with a physical therapy program or a control group. The study aims to determine if adding laser therapy provides better relief and improves daily physical functions compared to conventional treatment alone.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Apr 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Apr 2026Jul 2026

First Submitted

Initial submission to the registry

April 3, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2026

Expected
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 17, 2026

Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 3, 2026

Last Update Submit

April 10, 2026

Conditions

Keywords

LPLT

Outcome Measures

Primary Outcomes (1)

  • Pressure Pain Threshold (PPT)

    The minimum pressure at which a stimulus is perceived as painful, measured using a digital pressure algometer at specific trigger points. The device measures the pressure in kilograms per square centimeter (kg/cm²).

    Baseline and 2 months post-treatment.

Study Arms (2)

Participants will receive active laser therapy plus a standard physical therapy program (exercises a

EXPERIMENTAL

Participants will receive active laser therapy plus a standard physical therapy program (exercises and ultrasound)

Device: Low level laser therapyDevice: Therapeutic UltrasoundBehavioral: Physical Therapy Exercises

Control group have ultrasound and exercise and sham laser therapy

SHAM COMPARATOR
Device: Therapeutic UltrasoundBehavioral: Physical Therapy ExercisesDevice: Sham Laser Therapy

Interventions

"Patients will receive low-level laser therapy using a Gallium-Aluminum-Arsenide (GaAlAs) laser diode. Wavelength: 850nm, Power: 100mW. It will be applied to specific trigger points in the neck and shoulder area for 5 minutes per session, 3 times per week for 4 weeks."

Participants will receive active laser therapy plus a standard physical therapy program (exercises a

"Pulsed therapeutic ultrasound applied to the symptomatic area. Frequency: 1 MHz, Intensity: 1.5 W/cm², Duty cycle: 20%. The treatment will be applied for 5-8 minutes per session."

Control group have ultrasound and exercise and sham laser therapyParticipants will receive active laser therapy plus a standard physical therapy program (exercises a

A supervised physical therapy program focusing on stretching and strengthening exercises for the neck and shoulder girdle. This includes stretching of the scalene and pectoralis minor muscles, as well as strengthening of the middle and lower trapezius and serratus anterior. Each session lasts 30 minutes, twice per week for 8 weeks.

Control group have ultrasound and exercise and sham laser therapyParticipants will receive active laser therapy plus a standard physical therapy program (exercises a

"The same laser device will be used as in the experimental group, but without delivering any active laser energy. The device will be applied to the same points for the same duration to ensure blinding of the participants."

Control group have ultrasound and exercise and sham laser therapy

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age
  • Age between 35-50 years.
  • Clinically diagnosed with Thoracic Outlet Syndrome (TOS) by a physician based on standard diagnostic criteria.
  • Presence of neurogenic symptoms such as pain, paraesthesia, numbness, or --
  • weakness in the upper extremity.
  • Symptoms lasting for at least 3 months.

You may not qualify if:

  • History of cervical disc herniation or cervical radiculopathy.
  • Previous surgical intervention in the cervical or thoracic outlet region.
  • Severe cardiovascular or systemic diseases that may interfere with treatment. --Pacemakers or other implanted electronic devices.
  • Skin conditions or infections in the treatment area.
  • Receiving any other form of laser therapy or conflicting treatment during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Thoracic Outlet Syndrome

Interventions

Low-Level Light TherapyUltrasonic TherapyExercise Therapy

Condition Hierarchy (Ancestors)

Nerve Compression SyndromesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapyDiathermyHyperthermia, InducedRehabilitationAftercareContinuity of Patient CarePatient CarePhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master's Student, Faculty of Physical Therapy

Study Record Dates

First Submitted

April 3, 2026

First Posted

April 17, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

June 20, 2026

Study Completion (Estimated)

July 17, 2026

Last Updated

April 17, 2026

Record last verified: 2026-04